Skip links
Companies
› Spain › EVIDENZE HEALTH ESPAÑA S.L.
EVIDENZE HEALTH ESPAÑA S.L. logo

EVIDENZE HEALTH ESPAÑA S.L.

Private limited company (Ltd.) Active

Registration No.
B63286280
Incorporation Date
2003-01-01
Company Type
Private limited company (Ltd.)
Address
BARCELONA, Spain
Website
www.evidenze.com/
Source: Colegio de Registradores / Registro Mercantil Central

EVIDENZE HEALTH ESPAÑA, S.L. is a private limited company registered in Spain under CIF B63286280, recorded in the Registro Mercantil de Barcelona and shown as active as of 24 September 2026. It was incorporated on 1 October 2003 under the name Dynamic Science, S.L., adopting its current name on 19 December 2022. Its registered address is Passatge de Ferrer i Vidal, 8, 08005 Barcelona.

The company’s registered activity, classified under CNAE code 7219 (other research and experimental development in natural sciences and technology), is scientific and technical research in medical and health centres, including the design of clinical trial protocols, case report forms (data collection notebooks) and biostatistical reports. It operates within Evidenze, a pan-European outsourced pharmaceutical-services group headquartered in Barcelona that provides clinical research (CRO), digital health, medical training, consulting, patient-support and scientific-communication services to healthcare and pharmaceutical clients. On 27 June 2023 the sole shareholder approved the absorption by EVIDENZE HEALTH ESPAÑA, S.L.U. of five affiliated companies — BCNScience, Pulso Ediciones, Viguera Editores, Interactive Communication Projects and Edika Med, all S.L.U. — which were dissolved without liquidation and merged into the company, a transaction published in the Boletín Oficial del Registro Mercantil on 9 August 2023.

EVIDENZE HEALTH ESPAÑA, S.L. is not listed on any stock exchange. Commercial data providers report materially different staffing and turnover figures for the entity following the 2023 merger, with employee-count estimates ranging from roughly 68 to 285 and annual-revenue estimates from about €2 million to €50 million, so no single reliable company-level figure can be confirmed here.

Data Provenance
This record is sourced directly from official government registries, including Colegio de Registradores / Registro Mercantil Central.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

Shareholders of EVIDENZE HEALTH ESPAÑA, S.L.

An official merger filing published in the Boletín Oficial del Registro Mercantil records that EVIDENZE GROUP EUROPE, S.L. (CIF B02683175) was, as of a shareholder resolution dated 27 June 2023, the sole shareholder of EVIDENZE HEALTH ESPAÑA, S.L.U. and of five sister companies subsequently absorbed into it, consistent with the company’s status at that date as a “sociedad limitada unipersonal” (single-member limited company). No more recent Spanish registry filing confirming the current shareholder register was identified during this research, and commercial data aggregators publish only limited, inconsistent shareholder counts for the company that could not be independently verified. Separately, Columna Capital announced on 5 May 2026 a binding agreement to acquire a majority interest in the wider Evidenze Group from Buenavista Equity Partners, with co-founders Pedro Hernández and Albert Gallart retaining a minority interest; this transaction was reported at group level, and no filing was found confirming whether or how it altered the direct shareholder register of EVIDENZE HEALTH ESPAÑA, S.L. itself.

Data availability

Classification: Partial. The sole-shareholder relationship with EVIDENZE GROUP EUROPE, S.L. is verified through an official 2023 Registro Mercantil filing; no more current shareholder filing specific to this entity, and no verified ultimate beneficial owner, was identified.

Sources

  • Boletín Oficial del Registro Mercantil – BORME-C-2023-5420, merger filing, published 9 August 2023, boe.es
  • Columna Capital – press release, “Columna acquires majority stake in Evidenze Group from Buenavista Equity Partners,” 5 May 2026, columnacapital.com
  • Buenavista Equity Partners – press release, buenavistaequity.com
View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

2

Directors and officers of EVIDENZE HEALTH ESPAÑA, S.L.

EVIDENZE HEALTH ESPAÑA, S.L. is currently managed by two Administradores Solidarios (joint and several administrators), Enrique Centelles Satrustégui and Nuria Osés Múgica, both recorded as active in Spanish commercial-registry sources reviewed in September 2026. Exact appointment dates for the two administrators were not confirmed during this research. The company has also registered several Apoderados Solidarios (joint and several attorneys-in-fact) in recent filings, most recently Joan Escudero García, appointed 10 July 2026, and Bricio Vicente Rosario Teresa, appointed 26 November 2025. Spanish commercial-registry sources reviewed for this profile do not disclose nationality or country of residence for the company’s administrators.

Recent officer changes

  • Joan Escudero García appointed Apoderado Solidario (joint attorney-in-fact), 10 July 2026 (source: Registro Mercantil de Barcelona, via commercial-registry filings).
  • Bricio Vicente Rosario Teresa appointed Apoderado Solidario (joint attorney-in-fact), 26 November 2025 (source: Registro Mercantil de Barcelona, via commercial-registry filings).

Data availability

Classification: Partial. The Spanish Registro Mercantil publishes current administrator and attorney-in-fact appointments and role titles for EVIDENZE HEALTH ESPAÑA, S.L., but nationality, country of residence and exact appointment dates for the two Administradores Solidarios were not disclosed in the sources reviewed. One commercial-data aggregator separately listed two other individuals as “current directors” of the company; this could not be corroborated by the official Registro Mercantil filing or by other independent sources reviewed and has therefore been omitted from this overview.

Sources

  • Registro Mercantil de Barcelona – company filings, CIF B63286280 (via commercial-registry aggregators)
  • Boletín Oficial del Registro Mercantil – BORME-C-2023-5420, 9 August 2023, boe.es
View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

Group structure of EVIDENZE HEALTH ESPAÑA, S.L.

EVIDENZE HEALTH ESPAÑA, S.L. is not an independent company. An official merger filing published in the Boletín Oficial del Registro Mercantil confirms that, as of a shareholder resolution dated 27 June 2023, the company’s sole shareholder was EVIDENZE GROUP EUROPE, S.L. (CIF B02683175), a Madrid-registered holding company. The same filing records that five affiliated companies — BCNScience, Pulso Ediciones, Viguera Editores, Interactive Communication Projects and Edika Med, all previously wholly owned by EVIDENZE GROUP EUROPE, S.L. — were absorbed by EVIDENZE HEALTH ESPAÑA, S.L.U. and dissolved without liquidation; they are no longer separate legal entities. EVIDENZE HEALTH ESPAÑA, S.L. operates as part of Evidenze, a pan-European pharmaceutical-services group with an operational headquarters in Barcelona and offices in Portugal, Italy and Germany; a majority interest in the wider group was reported, in a binding agreement announced 5 May 2026, to be acquired by the private-equity firm Columna Capital from Buenavista Equity Partners, with co-founders Pedro Hernández and Albert Gallart retaining a minority interest. No official filing was found identifying a specific ultimate holding entity above EVIDENZE GROUP EUROPE, S.L., so this reported group-level transaction is described here as unverified at the legal-entity level. No verified current direct or indirect subsidiaries of EVIDENZE HEALTH ESPAÑA, S.L. itself were identified.

Verified corporate relationships

Entity Country Registration number Relationship Ownership Status Information date
EVIDENZE GROUP EUROPE, S.L. ES B02683175 Immediate / sole parent Sole shareholder (100%, per 2023 filing) Active 27 Jun 2023 (BORME filing)

Recent structural changes

  • Absorption of BCNScience, S.L.U., Pulso Ediciones, S.L.U., Viguera Editores, S.L.U., Interactive Communication Projects, S.L.U. and Edika Med, S.L.U. by EVIDENZE HEALTH ESPAÑA, S.L.U., approved 27 June 2023 and published in BORME 9 August 2023 (source: Boletín Oficial del Registro Mercantil).
  • Reported binding agreement for Columna Capital to acquire a majority interest in the wider Evidenze Group from Buenavista Equity Partners, announced 5 May 2026 (source: Columna Capital, Buenavista Equity Partners press releases) — not confirmed at the level of this legal entity.

Data availability

Classification: Partial. The sole-shareholder relationship with EVIDENZE GROUP EUROPE, S.L. and the 2023 merger are verified through an official Registro Mercantil filing; no current filing confirming the shareholder register beyond that date, and no verified ultimate parent entity, was identified.

Sources

  • Boletín Oficial del Registro Mercantil – BORME-C-2023-5420, merger filing, published 9 August 2023, boe.es
  • Columna Capital – press release, “Columna acquires majority stake in Evidenze Group from Buenavista Equity Partners,” 5 May 2026, columnacapital.com
  • Buenavista Equity Partners – press release, buenavistaequity.com
Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on EVIDENZE HEALTH ESPAÑA S.L.?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

What does EVIDENZE HEALTH ESPAÑA S.L. do?

EVIDENZE HEALTH ESPAÑA, S.L. (CIF B63286280) is a private limited company registered in the Registro Mercantil de Barcelona, incorporated 1 October 2003 as Dynamic Science, S.L. and renamed on 19 December 2022; classified under CNAE 7219, it carries out scientific and technical research in medical and health centres, including clinical trial protocols, case report forms and biostatistical reports, as part of the pan-European Evidenze pharmaceutical-services group.

Who owns EVIDENZE HEALTH ESPAÑA S.L.?

An official 2023 Registro Mercantil filing records EVIDENZE GROUP EUROPE, S.L. (CIF B02683175) as the sole shareholder of EVIDENZE HEALTH ESPAÑA, S.L.U.; no more recent shareholder filing specific to this entity was identified.

Who is EVIDENZE HEALTH ESPAÑA S.L.'s UBO (Ultimate Beneficial Owner)?

No Ultimate Beneficial Owner (UBO) data is recorded for EVIDENZE HEALTH ESPAÑA S.L.; access to beneficial-ownership data in this jurisdiction is governed by its own register rules.

What is EVIDENZE HEALTH ESPAÑA S.L.'s company registration number?

EVIDENZE HEALTH ESPAÑA S.L.'s registration number is B63286280, filed with Colegio de Registradores / Registro Mercantil Central in Spain. Its current status on the register is active.

Is EVIDENZE HEALTH ESPAÑA S.L. still an active company?

EVIDENZE HEALTH ESPAÑA S.L.'s status on Colegio de Registradores / Registro Mercantil Central is listed as active.

When was EVIDENZE HEALTH ESPAÑA S.L. incorporated?

EVIDENZE HEALTH ESPAÑA S.L. was incorporated on 1 January 2003, according to Colegio de Registradores / Registro Mercantil Central.

What is EVIDENZE HEALTH ESPAÑA S.L.'s registered address?

The registered address on file for EVIDENZE HEALTH ESPAÑA S.L. is BARCELONA, Spain.

What legal structure is EVIDENZE HEALTH ESPAÑA S.L. registered as?

EVIDENZE HEALTH ESPAÑA S.L. is registered as a Private limited company (Ltd.) in Spain.

Is EVIDENZE HEALTH ESPAÑA S.L. listed on a stock exchange?

EVIDENZE HEALTH ESPAÑA, S.L. is not listed on any stock exchange.

Who are the officers/directors of EVIDENZE HEALTH ESPAÑA S.L.?

EVIDENZE HEALTH ESPAÑA, S.L. is managed by two Administradores Solidarios, Enrique Centelles Satrustégui and Nuria Osés Múgica, with recent Apoderado Solidario appointments including Joan Escudero García (10 July 2026) and Bricio Vicente Rosario Teresa (26 November 2025).

Does EVIDENZE HEALTH ESPAÑA S.L. have a parent company or subsidiaries?

EVIDENZE HEALTH ESPAÑA, S.L. is wholly owned by EVIDENZE GROUP EUROPE, S.L. per a 2023 Registro Mercantil filing, and absorbed five affiliated companies (BCNScience, Pulso Ediciones, Viguera Editores, Interactive Communication Projects and Edika Med) that year; it operates within the wider Evidenze pharmaceutical-services group, a majority stake in which Columna Capital agreed to acquire from Buenavista Equity Partners in May 2026.

Can Zavia monitor changes to EVIDENZE HEALTH ESPAÑA S.L.'s ownership over time?

This profile reflects a point-in-time snapshot from Colegio de Registradores / Registro Mercantil Central. Zavia's monitoring API can track changes to EVIDENZE HEALTH ESPAÑA S.L.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access EVIDENZE HEALTH ESPAÑA S.L.'s data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Spain, so records like EVIDENZE HEALTH ESPAÑA S.L.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from Colegio de Registradores / Registro Mercantil Central and was last synced on 24 September 2026.

This website uses cookies to improve your web experience.